Meyka Pro banner
Europlasma S.A.

Europlasma S.A. Fundamental Analysis (MUN: 1EZ0.MU)

1EZ0.MUMUN
IndustrialsWaste Management
0.001
0.00(0.00%)
German Market is Open · 16:59

Europlasma S.A. Fundamental Analysis (MUN: 1EZ0.MU)

Europlasma S.A. (MUN: 1EZ0.MU) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -50.54%, and ROE of 1.77%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position1198273.10%
PEG Ratio0.00

Areas of Concern

ROE1.77%
Operating Margin-49.11%
Current Ratio0.66
We analyze 1EZ0.MU's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -45.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-45.9/100

We analyze 1EZ0.MU's fundamental strength across five key dimensions:

Efficiency Score

Weak

1EZ0.MU struggles to generate sufficient returns from assets.

ROA > 10%
-48.07%

Valuation Score

Excellent

1EZ0.MU trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
0.00

Growth Score

Weak

1EZ0.MU faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

1EZ0.MU shows balanced financial health with some risks.

Debt/Equity < 1
-0.94
Current Ratio > 1
0.66

Profitability Score

Weak

1EZ0.MU struggles to sustain strong margins.

ROE > 15%
177.16%
Net Margin ≥ 15%
-50.54%
Positive Free Cash Flow
No

Key Financial Metrics

Is 1EZ0.MU Expensive or Cheap?

P/E Ratio

1EZ0.MU trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, 1EZ0.MU's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Europlasma S.A. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 0.46 times EBITDA. This is generally considered low.

0.46

How Well Does 1EZ0.MU Make Money?

Net Profit Margin

For every $100 in sales, Europlasma S.A. keeps $-50.54 as profit after all expenses.

-50.54%

Operating Margin

Core operations generate -49.11 in profit for every $100 in revenue, before interest and taxes.

-49.11%

ROE

Management delivers $1.77 in profit for every $100 of shareholder equity.

1.77%

ROA

Europlasma S.A. generates $-48.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-48.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Europlasma S.A. generates limited operating cash flow of $-66.25M, signaling weaker underlying cash strength.

$-66.25M

Free Cash Flow

Europlasma S.A. generates weak or negative free cash flow of $-89.03M, restricting financial flexibility.

$-89.03M

FCF Per Share

Each share generates $-34.33 in free cash annually.

$-34.33

FCF Yield

1EZ0.MU converts -8235.63% of its market value into free cash.

-8235.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.94

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.77

vs 25 benchmark

ROA

Return on assets percentage

-0.48

vs 25 benchmark

ROCE

Return on capital employed

-7.26

vs 25 benchmark

How 1EZ0.MU Stacks Against Its Sector Peers

Metric1EZ0.MU ValueSector AveragePerformance
P/E Ratio-0.0029.39 Better (Cheaper)
ROE177.16%1109.00% Weak
Net Margin-50.54%-25189.00% (disorted) Weak
Debt/Equity-0.940.82 Strong (Low Leverage)
Current Ratio0.6621.75 Weak Liquidity
ROA-48.07%-1328226.00% (disorted) Weak

1EZ0.MU outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Europlasma S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

EPS CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

FCF CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

Fundamental Analysis FAQ